Global Geriatric Medicines Market Analysis & Forecasts 2017-2026, With an Expected CAGR of 9.3% - ResearchAndMarkets.com

June 13, 2018

DUBLIN--(BUSINESS WIRE)--Jun 13, 2018--The “Geriatric Medicines - Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering.

According to the publisher, the Global Geriatric Medicines Market is expected to grow at a CAGR of 9.3% during the forecast period.

Increasing occurrence of diabetes and cardiovascular diseases amongst old people, increase in government support, improving healthcare infrastructure in number of upcoming economies are some of the key factors favouring the market growth. However, factors such as lack of awareness need of patient participation in clinical trials and side effects of medicines are hindering the market growth.

Geriatrics is a division of medicines connected to the remedial, clinical, social, and preventive aspects of ill health among old people over 65 years. The majority of the geriatrics is not capable to take their medication correctly at the intended time due to difficult in psychological and medical issues. The geriatric inhabitants need special attention and care for the rapid recovery of disorder or disease.

By Therapeutic Category, antihypertensive segment is projected to have significant share during the forecast period. Antihypertensive are a group of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy prevents problems of high blood pressure such as stroke and myocardial infarction. Restless lifestyle of the urban populations and growing life expectancy are favouring the growth of antihypertensive medicines for geriatrics. By Geography, North America region is projected to grow at a significant rate due to high prevalence of chronic diseases, favourable administration initiative for the old people and presence of some pioneering companies of this market.

Companies Mentioned

Abbott Laboratories, Inc. AstraZeneca plc Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Eli Lilly and Company GlaxoSmithKline Plc. Merck & Company Inc Novartis AG Pfizer, Inc. Sanofi S.A

Key Topics Covered:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Geriatric Medicines Market, By Therapeutic Category

6 Global Geriatric Medicines Market, By Condition

7 Global Geriatric Medicines Market, By Geography

8 Key Developments

9 Company Profiling

For more information about this report visit https://www.researchandmarkets.com/research/48pn8z/global_geriatric?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180613005523/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drugs by Therapeutic Area



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/13/2018 07:22 AM/DISC: 06/13/2018 07:22 AM


Update hourly